Saturday, February 04, 2012

History of spirometry (the pulmonary function test)

John Hutchinson (1811-1861)
If you're an asthmatic chances are your doctor has had you perform a pulmonary function test (PFT).  The Mayo Clinic states this is a test that measures how much air you can blow in and out, and it's a good test to help your doctor diagnose asthma or to monitor the course of your asthma over time.

During this test you blow into a spirometer which measures your lung volumes, and it's for this reason PFT testing is more historicaly referred to as spirometry.  Over the past 30 years I've performed hundreds of these tests, and while my PFTs now are relatively normal, once when I was about 12 I had a PFT test show I had only a 35 percent lung function (obviously it was during an asthma attack).

The first recorded spirometry test was perfomed by Greco-Roman physician Claudius Galen way back in the period of 129-200 A.D.  He had a boy blow into and out of a bladder, and he found that the volumes exhaled do not change over time.  Yet Galen wasn't able to measure the volumes, he simply used his keen eye and observation, according to Ann Kiraly in her 2005 award winning article, "History of Spirometry." (1)

While others may have performed similar experiments nothing significant was recorded until Giovannin Alfonso Borelli had a volunteer plug his nose to assure an accurate measurement of lung volumes, and to prevent air from escaping or entering from the nose.  He is believed to be the first person to have have a patient block the nose, a technique that is still done to this day during spirometry testing. (2)

In 1679 Borelli became the first to measure the amount of air entering the lungs.  He did this by sucking liquid up a tube.  (3)

In 1793 John Abernathy developed a method of collecting expired gas over mercury and attempted to determine how much those gases had been used up by the body.  He thought this was important because exhaled oxygen should be less than what is inhaled.  He also determined that exhaled oxygen would be higher in patients with certain lung diseases. (4)

He also measured a vital capacity (VC) of  3110.   Vital capacity is the total amount of air one can exhale from the lungs. A VC of 3110 may have been normal for that person, considering a normal VC is now determined to be 4-5 liters.

Davey's Gasometer*
In 1800 Sir Humphrey Davey created what he called a gasometer (a container that stores gas) that allowed him to measure various lung volumes.  He measured his own vital capacity at 3111 ml.

He measured his tidal volume at 210 ml.  Tidal volume (VT) is another word for normal breath. A VT seems kind of low, although it may have been normal based on Davey's height and age.

He also calculated his residual volume to be about 600 ml.  Residual volume (RV) is the amount of air that stays in your lungs after a normal exhalation.

To put these volumes into perspective, VC = RV + TV.  While the technique used is now different, these same volumes are measured by today's spirometers.  Davey also devised a mechanism to determine how much oxygen was utilized by the body and how much carbon dioxide his body created.  (5)

In the following years many others performed similar experiments.  Herman Boerhaave (1668-1738) "measured the difference in the level of water in his bath tub during the two phases of respiration,"   according to Paul Lois Tissier in his 1903 book "Pneumotherapy: Including Aerotherapy and Inhalation Methods and Therapy.

Several others collected air in a bell-jar filled with water.  So there were various techniques performed by a variety of physicians and scientists over the years who tried to measure lung volumes.  Yet it wasn't until 1846 that an effective spirometer was invented, and the inventor given credit is John Hutchinson.

Hutchinson's Spirometer
Tissier explained that Hutchinson "taught the importance of physiologic research and devised the instrument which bares his name."  Basically Hutchinson's spirometer is a combination of techniques used by other inventors who existed before him.  For example, his consisted of a bell jar immersed in water.  

Tissier explained Hutchinson's spirometer this way:  "The jar hung in cords which pass over pulleys attached to two vertical supports, is counterbalanced by weights. The air, first expired by a mask applied to the patient's mouth, is conducted through an external rubber tube and then through a metalic tube in the interior of the reservoir to the upper portion of the bell jars.  As soon as expiration takes place, the air enters the jar and the later rises.  The distance transversed by the jar is read of on a graduated scale, and the volume of expired air is then calculated."

Hutchinson determined that the volume of exhaled air (VC) has a linear relationship with height.  As we now know, the taller a person the longer the lungs, and the more air they can hold.  In other words, he was right.  

Hutchinson also invented a portable spirometer "where respiratory capacity is measured by the movement of a pointer.  By the turn of the 19th century Hutchinson's model had been modified "but a little."  (7)

Modern PFT equipment
The most significant adjustment to this device was made by Dr. Wintrich in 1856 who adjusted the bell jar so that it was movable and supported by a single rod.  Most experts believed Wintrich's improvements made the Hutchinson's spirometer much more accurate and much more easy to use. (8)

Kiraly explained that Wintrich was also the first to determine that the best way to measure VC can be estimated by a measurement of a person's height, age and weight.  This same measurement is used to this day.

The spirometer has been modified many times through the years since Hutchinson's invention, yet the only significant changes are that graphics are now used and the bell jar is smaller.  Oh, and we should also note the system has now been computerized.

Either way, spirometry, often referred to as pulmonary function testing (PFT),  remains a significant test used to help physicians diagnose and monitor the course of disease.


References:
  1. Creative-biotech.com, "History of Spirometry and Lung Function Test, http://creative-biotech.com/special-offer/history-of-spirometry-and-lung-function-test/
  2. Journal of Pre-health Affiliated Students, JPHAS, "History of Spirometry," Winter 2005, Volume 4, Issue 1,  http://www2.uic.edu/orgs/jphas/journal/vol4/issue1/features_ak.shtml
  3. Brockbank, E.M., ed., "The Medical Chronicle: A Monthly Record of the Progress in Medical Science," October 1905 to March 1906, Vol. XLIII, Boston, page 301,
  4. JPHAS, "History of Spirometry, ibid, same post as above
  5. JPHAS, "History of Spirometry, ibid, same post as above
  6. Tissier, Paul Lois, "Pneumotherapy: Including Aerotherapy and Inhalation Methods and Therapy," 1903, Philadelphia,  page 29)  Herman Boerhaave (1668-1738) 
  7. Tissier, ibid, page 29
  8. Tissier, ibid, page 29
  9. *Pictures compliments of JPHAS
Further readings:
  1. You can read more about some of the 19th century spirometers and even see some pictures by clicking here.  
  2. To read an awesom and much more precise account of the history of the spirometer check out Ann Kiraly's article ," which was a 2nd place entry in the Spring 2004 Health Science Writing Competition.  Her article was published in the Journal for Pre Health Affiliated Students and can be reached by clicking here.  

Wednesday, February 01, 2012

History of Asthma in the 19th Century

Today we're going to go for a ride in our time machine through the 19th century.  Grab a cup of coffee, hop into our cozy little machine, lean back, put your feet up, and enjoy.

Debunking ancient theories of asthma:

Our time machine takes us back to 400 B.C and we watch as Hippocrates and his fellow physicians study respiratory disorders and work on defining asthma as a medical term.  Now we fast forward to the year 1816 on a hot and humid day in France and find Rene Laennec leaning with his ear on one end of rolled up bundle of papers, with the other end on the chest of a large, dusky, perspiring lady who's hunched up on the docotr's bed panting for air. 

The object he's using is clearly the first stethoscope, yet on this day he simply called it  le cylindre.  It would be a few years before he would be pressured by his peers into calling his object the stethoscope.  It would turn out to be a revolutionary device responsible for the evolution of a term called asthma throughout the rest of the 19th century.  Laennec perhaps had no clue his invention would set off a hunt to redefine asthma, or at least provide the tool for such a task. 


Laennec's stethoscope
 Over the ensuing years, of which go by fast in the comfy confines of our time machine, we see a growing number of physicians using this tool to help them better diagnose and treat their patients.  And it was mainly this tool that sparked a hunt by asthma physicians to redefine asthma so it represents the disease as we know it today.  Yet how this evolution occurred is the purpose of our journey through time. 

Through our travels thus far we've learned the Ancient Greeks used the term asthma to describe any condition that causes dyspnea, or shortness of breath.  So your dyspnea could be caused by heart failure, kidney failure, or any number of respiratory disorders, and it would still be called asthma.  Hence the terms kidney asthma and cardiac asthma.

William Pepper and Louis Star, in their 1885 book "A System of Practical Medicine" explained that prior to the 19th century all dyspnea and all that wheezes were designated as asthma.

They wrote about the term as covering such an "extensive range of territory, it was found necessary to subdivide the disease into a number of varieties, each author classifying them according to his conception of the cause, seat, and nature of the trouble. Some of these -- e.g.a. dispepticum, still find their place in medical literature, but the vast majority of them, having ceased to be of any practical significance, have been discarded, and are now only interesting as examples of the crude and fanciful notions which prevailed in an age during which science rather retrograde than advanced." (1)

In 1878 J.B. Berkart, in his book,  "On Asthma: It's pathology and treatment" made the same observation
"ALL early historical traces of the affection at present called asthma are lost. Although the disease is said to be mentioned in the Bible, and described by Hippocrates, Areteaus, Galen, and Celsus, there is not the least evidence that those remarks apply to the asthma of to-day. For in the former systems of medicine, all cases presenting the same conspicuous symptoms were, regardless of their anatomical differences, considered as of a kindred nature, and grouped into classes according to imaginary types. (2)
In essence, Laennec's discovery sparked a leap through time.  Where 7,000 years of asthma suffering resulted in little progress in the way of asthma wisdom and treatment, the next 81 years would provide for asthmatics more than all those 7,000 years combined. 

We learn that between 1816 and 1900 many different theories about what causes asthma were created, and every one of these theories had its followers.  Each expert wrote his own definition of asthma based on his beliefs about the disease, and his own remedies based on these beliefs.

This was all done in the process of fine tuning the definition of asthma.  Yet in the end, we learn through our time traveling the two theories that won the day were the bronchospasm theory of asthma (often referred to as the spasmotic or convulsive theory of asthma) and the nervous (psychosomatic) theory of asthma. 

By the end of the 19th century the ground would be set for an even bigger leap through time as far as asthmatics are concerned.  By 1899 adrenaline was isolated, and this set off a wave of wisdom that would greatly improve the lives of asthmatics. Yet for the time being (no pun intended), we find ourselves drifting from cozy doctor's offices in large Victorian homes to laboratories of some of the worlds greatest asthma experts. 

First, an attempt to defend ancient asthma theories:

The treatment of asthma is relative to the cause.  Before Hippocrates, for example, asthma-like diseases were often believed to be caused due to a spirit, and the remedy would be chants and hymns to expectorate the evil spirit.  Occassionally a family member would know of a herbal remedy for you to try, perhaps something mixed in tea, or smoked in a crude pipe. 

Hippocrates believed asthma was caused by an imbalance of the four humors -- yellow bile, black bile, phlegm and blood -- and disease were caused by an imbalance of these humors.  This was pretty much the belief of both western and eastern societies.  So one remedy would be bleeding to expectorate excess blood, while another would be concoctions believed to warm the patient. 

Galen, Aurelius Celsus, and other ancient asthma experts may have differed slightly in their descriptions and remedies, yet for the most part they believed in the humoral theory of asthma.  Yet William Cullen in the 18th century swayed from these teachings based on science, and he came up with the more modern nervous and spasmotic theories of asthma.

Robert Bree, however, was an English physician who believed such modern theories were the subject of quackery.  He set out to prove Cullen wrong and ancient asthma experts closer to the truth in his 1797 book "A Practical Inquiry into Disordered Respiration, distinguishing the Species of Convulsive Asthma, their Causes, and Indications of Cure.  (3)

First of all, he wrote that the no science proved the nervouse or spasmotic theory of asthma, especially considering those two conditions cannot even be observed in autopsy.  He said you can see phlegm on autopsy, so science supports his theories and those of Galen and Celsus more so than Cullen's.

Now, Bree did not completely reject the spaspotic theory of asthma, he simply considered it as secondary to some other cause.  Ernest Schmiegelow explained this in his book "Asthma, considered specially in relation to nasal disease," (1890 page 4).  He wrote that:
"Bree does not actually deny the possibility of bronchial spasms taking some part in the cause of asthma, but it is only secondary; the primary cause is an exudation in the bronchial tubes, by which the lungs (specially the muscles of respiration) are stimulated to contraction, in order to expel the mucus which they contain." (4)
In other words, Bree believed that mucus was the cause of most diseases, including asthma.  He believed the contraction of the lungs was a defense mechanism to expel mucus from the lungs. Bree's ideas about asthma are important to our 19th century history because he was considered by many the preeminent asthma expert of the first half of that century.

George Lipscomb was a fellow asthma expert from England who set out to prove Bree wrong.  As Mark Jackson described in his 2006 book "Asthma: The Biography," Lipscomb's goal was not to discredit Bree, his goal was to 'elucidate the history of a very prevalent and distressing disease, which has been hitherto but ill explained, and very unsuccessfully treated."

Lipscomb published his own theories in his 1800 book "Observations on the history and Cause of Asthma."  Lipscomb argued that Bree could no more prove Cullen's theories were wrong than Cullen could prove them right because upon death the lungs automatically relax." (5)

So the debate was on.  While experts were hard pressed to find evidence to prove either theory, Schmiegelow explained that Bree's theory was disproved as soon as the stethoscope gained favor, as it's easily proven an attack of bronchitis does not precede asthma, and that rales (a lung sound) are heard later during the attack.

Likewise, while Bree was well respected in his day, his ideas about asthma, and even most of his remedies, would slowly give way to to the spasmotic theory of asthma and the nervous theory of asthma

Asthma experts set out to prove their theories of asthma:

The nervous theory of asthma was first described in the 17th century by Jean Baptiste van Helmont and Thomas Willis, and in the 18th century by William Cullen.  Most asthma experts in the 19th century believed wholeheartedly that asthma was caused by a nervous response, and the evidence -- so they thought -- was overwhelming.

Ironically, when Cullen's convulsive theory of asthma was proven, this did nothing to disprove the nervous theory.  In fact, many experts would go on to prove that beyond a reason of a doubt the convulsive theory of asthma further proved their nervous theory of asthma.

In 1808 Franz Reisseisen performed experiments that proved muscular fibrers wrap around the air tubes of the lungs, according to Jenny Bryan in her book "Asthma."  (6)  In our day we know these muscular fibres are smooth muscles we call bronchial muscles. 

Jackson explains that Bree attempted to prove his theories by dissecting the lungs of asthmatics who died of an attack, however this was a problem because asthmatics rarely died.  He therefore had to dissect the lungs of people who died of other diseases that were similar to asthma. 

Sure, it's true, that many asthma experts throughout the 19th century would note that few asthmatics died from their attacks; that asthma was more of a neusance than something that caused death.  (Henry Hyde Salter noted this, and so did William Henry Osler -- the father of modern medicine -- near the end of the century.)  While this may have been good -- or maybe not -- for most asthmatics, it didn't bode well for science.

Either way, by 1808 Franz Reissesen discovered that the fibres wrap around the air passages of the lungs even to the "minutest bronchi," according to Pepper and Starr.  As these fibres contract, the air passages of the lungs become narrower. 

Rene Leannec's 1816  invention of the stethoscope allowed physicians to differentiate the unique sounds of asthma from other diseases.  Laennec believed in the convulsive (bronchospasm) theory of asthma, and he also believed catarrh (inflammation) to be the most frequent cause of asthma.

Like Bree, he attempted to compare signs and symptoms of disease during life with what he saw on autopsy.

James Thomas Whitaker in his 1893 book, "The theory and practice of medicine" quotes Leannec as saying "Few terms have been so abused in medicine or made to designate such different diseases (than asthma)."  By using his new stethoscope, he aimed to prove asthma was a disease of bronchospasm and nothing more.

Laennec was the first to use such descriptions as rhales and rhonchi to describe lung sounds heard by auscultation, and the sounds heard during an asthma attack he described as rhonchi.

Rhonchi would later be divided into sibilant and sonorous, with sibilant rhonchi (now called a wheeze) being the sound of air traveling through narrowed airways, and sonorous rhonch (now called rhonchi) being the sound of air traveling through secretion filled airways.

The Race to define asthma was on:

The rest of the 19th century consisted of one physician after another coming up with his theory as to the cause of asthma.  Each was convinced he was right, and each offered the best proof he could.  Historians can argue whether this slowed down search for better asthma wisdom, or actually sped it up.

Franz Daniel Reisseissen was a German physician who studied the lungs, and he concluded that "there is another apparatus appointed for contracting the bronchi, which consists of transverse muscular fibres.  As far as the cartilaginous rows extend, these fibres are inserted...." (7)

In other words, according to "The Cyclopaedia of practical medicine" (edited by John Floyer in 1833, volume 1, page 186), Reissiessen proved muscle fibres wrap around the air passages of the lungs almost all the way to the alveoli.  His writings were published in Berlin in 1822.

It wasn't until "the paper by Francis Hopkins Ramadge (1835, you can view his book here*.) and the prize essays of Bergson and Lefevre (1836) that asthma was really regarded as a neurosis of the respiratory organs," according to Whitaker. (8)

Barry E Brenner described in "Emergency Asthma" (edited by Barry E. Brenner, 1998, page 7) wrote that Ramadge described food as an asthma trigger, recommended moving from the city to country,  and of asthma being mostly a nocturnal disease. He discouraged use of opiates because they impede respirations that are already impeded. He mainly recommended strammonium because it "produces a grateful forgetfulness and a balmy oblivion like opiates." (9)

J.B. Berkart in his 1878 book "On Asthma:  It's Pathology and Treatment" (volume I, page 23) described that Lefevre observed his own asthma and that of a friend and concluded asthma could only be caused by bronchospasm.  Yet he (Lefevre) believed this bronchospasm was caused by the mind.  (10)

Berkart wrote that "in essence of the disease he (Lefevre) considered to be an increased irritability of the nerves of the lungs, in consequence of which the slightest irritation applies to the bronchial surface induced spasm of the bronchial tubes." (10)

Whitaker wrote that the view of asthma as a nervous disease was further established by "Romberg (1841) who based his conception of the disease as a spasmus bronchialis, upon the discovery by Reiseissen (1808) of muscular tissue in the finer bronchial tubes, and the contraction of these tubes under galvanization of the lungs by Charles J.B. Williams (1840), and irritation of the vagus (nerve) by Dr. Francois Achille Longet (1842)."

According to William Pepper and Louis Star, "It was ascertained by Williams that by irritating the lung he could cause contraction of these fibres, and Longet subsequently proved that the same effect could be produced by galvanizing the pneumogastric nerve."  (11)

Berkart wrote that Williams performed experiments that proved without a doubt "that mechanical and electrical stimuli do produce contraction of the air-tubes. Thus the theory of a bronchial spasm obtained the support of experimental physiology. And even those who until then wavered in their opinions as to the possibility of such a spasm saw now no reason for doubting, but readily accepted that doctrine."

Williams must have agreed with Laennec and Berkart that asthma was an abused term.  Whitaker noted that in 1768 there were 17 different types of asthma (as described by Savage) and in 1822 this was reduced to 11 (by Richter). This was confusing.  Williams wanted to simplify the definition of asthma.

Williams became the first to break asthma into two types: spasmodic and paralytic. Berkart wrote that as of the writing of his (Berhart's) book, the two terms described by Williams were the ones accepted by most experts.  However, other doctors would continue to reclassify asthma to their own content and amusement.

Yet while his research led Williams in the correct direction, along came Dr. Francois Achille Longet who, in 1842, did experiments of his own only to prove that, as Berkart wrote (page 27) that "irritation of the pneumogastric nerve always produced spasmodic contraction of the bronchi, whereas section of the nerve led to emphysema, which was described as distention of the air vesicles (what we now call air trapping)."  (12)

Longet also believed bronchospasm and emphysema (air trapping) were both parts of asthma. If we could hop into our virtual time machine we could tell him he was right. We could tell him that spasming of the bronchiole muscles (which he referred to as fibres) caused air to become trapped in the alveoli. This we know is air trapping, or what what was grouped back then under the term emphysema.

If we could do that we could have put an end to the whirlwind of theories that I think delayed progress that may have resulted in beta adrenergic medicine to relax these smooth muscles long before they were finally discovered in 1900. We could have stopped the whirlwind of false steps and experiments that lead to poppycock theories such as the nervous theory of asthma.

So in 1840 Charles Williams -- who was ultimately the same person to come up with the term lub dub to describe the beating of the two chambers of the heart -- became the first to prove that certain irritants cause contraction of the muscular fibres that Reisseissen proved wrap around the air passages in the lungs. 

In 1848 histologist Rudolph A. von Killiker confirmed the works of Williams and Reisseissen when he isolated smooth muscles of the lungs, according to John Daintith in his book "Biographical encyclopedia of scientists."  (13)

This essentially proved Cullen wrong, that the muscle was not just a continuation of a nerve.  Yet since nerves still connected to muscles, van Killiker's discovery was unable to stop the fallacy of the nervous theory of asthma.

The thing to note about most of these experts is that even while they believed in the bronchospasm theory of asthma, they continued to believe it the nervouse theory of asthma, and their experiments prooved the two co-existed  -- or so they thought.

An attempt to disprove the convulsive theory of asthma:

In 1840 William Budd flat out rejected the bronchospasm theory of asthma. Berkart wrote extensively about Budd, and how he aimed to disprove the convulsive theory of asthma

Budd repeated experiments previous authors wrote would produce bronchospasm and he didn't produce the same results. In fact, Berkart wrote that Budd flat out "rejected the theory of a bronchial spasm, and even doubted whether the circular fibres were muscular, as alleged."

Budd, thus, did not believe the fibres discovered to be wrapped around the air passages of the lungs were muscular, let alone that they spasmed and caused narrowing of the air passages that resulted in asthma.

So now we had proof the bronchospasm theory of asthma was fallacious. Or did we?
Budd was proven wrong that same year by Dr. Charles J. B. Williams.

The invention of the spirometer:

1846 was another big year in the history of asthma as this was the year the spirometer was invented.   This is a tool that would ultimately help physician measure lung volumes and differentiate between the different causes of dypsnea.  I wrote more about the spirometer in this post.

Proof once again that asthma was spasmotic:

In 1851, Berkart wrote, a man named Romberg (once agin his last name eludes us) as describing asthma as two different affections of the vagus nerve, and he called them bronchospasm and paralysis (which I think is emphysema, yet I'm not 100 percent positive here).

However, that same year Bergson (first name???) denied paralytic asthma existed and he did experiments to prove asthma was only spasmotic (was bronchospasm). Actually, John Reid did experiments earlier, Bergson just appied his experiments and theories to the understanding of asthma.

Still, while Bergson believed asthma was spasmotic in nature, he believed the cause was nervous.
However, in 1864 Alfred Wilhelm Volckman did experiments that once again verified the bronchospasm theory, yet he could find no evidence of the nervous link to asthma.  Volkman said he saw no spasms of the muscular fibres surrounding the air passages as a result of stimulation of the vagus. 

Berkart also wrote about the theories laid down by Beau Cozart in 1851 that rejected asthma was a disease of bronchospasm and rejected the nervous theory.  He (Cosart)  insisted asthma was a disease caused by increased sputum in the lungs that was capable of blocking the air passages with mucus plugs.  If we could jump into our time machine we could tell him he was right, yet he shouldn't be so quick to reject bronchospasm.

Yet it didn't matter, because the nervous theory of asthma had already won the hearts of so many asthma experts that little attention was paid to this sputum theory of asthma.  It didn't help that Beau provided no proof to his theories.

Pepper and Star note that Williams and Longet's bronchospasm of asthma met with "little opposition until 1884, when (M. Alton) Wintrich, after a series of experiments, arrived at conclusions directly opposed to those of Williams and Longet in regard to the contractility of the muscular fibres of the bronchi, and refused to accept the spasm theory on the grounds that it afforded no rational explanation of the phenomena of asthma."

Berkart wrote that Wintrich believed bronchospasm was only a mild part of asthma, and that tetanus (tonic spasm according to Pepper and Starr) of the diaphragm alone (an idea first proposed by Thomas Wilson in the 17th century) or tetanus of the muscles of respiration with spasm of the glottis or other muscles of respiration were the main causes of asthma.  Yet Wintrich may have been thinking of dyspnea more so than asthma.

Wintrich likewise believed bronchospasm was impossible, Berkart wrote (page 34).  Instead, he believed dyspnea was primarily a "disturbance of innervation."  In other words, that it caused by a disturbance of nerves to the lungs, according to dictionary.com.

Wintrich --and again in 1870 Banberger -- believed asthma was caused by spasm of the diaphragm. In 1870 Biermer believed it was a disease of the bronchial tubes, and in 1873 Leber wrote that he believed in both these theories.

In 1873 Leber believed asthma was caused by dilation of the blood vessels in the lungs. In fact, this theory was still believed to be true when epinephrine was later invented in 1900, as the vasoconstricting component of epinephrine was believed to increase blood flow to the lungs and thus made breathing easier that way.

Yet his theory was shunned almost as soon as it was developed.

It's interesting to note that Pepper and Star likewise wrote that Wintrich's experiments were so thoroughly done, and he was so highly regarded as a specialist in respiratory medicine, that his theories gained much support, "and might perhaps have been generally accepted had it not been for the distinguished French physiologist, Paul Bert, who in 1870, with improved methods of scientific research, succeeded in demonstrating that Willis and Longet were after all correct in their statements as to the contractility of the bronchial muscles."

While the bronchospasm theory of asthma was gaining steam, the the debate as to what causes asthma was ongoing. 

More back and forth debates as to what causes asthma:

Remember Budd?  He's our asthma expert from 1840 who flat out rejected the bronchospasm theory of asthma.  In 1855 Guillaume Benjamin Amand Duchenne proved Budd right, or so he thought.  As Berkart wrote, Duchenn proved "faradisation of the phrenic nerve caused tetanus of the diaphragm.  (You can view Duchen's book here**)

So who cares what causes the symptoms, Berkart wrote of Constatt, who believed it doesn't matter the cause of dyspnea because antispasmotics (like belladona found in asthma cigarettes) work equally well for both asthma and emphysema.

Pretty much Constatt was correct, yet with greater wisdom comes greater treatments as we would learn in 1900.

Another neat theory that came along in 1855 was by a Dr. Ludwig Traube who denied nervous asthma but believed asthma was rare and the dyspnea that resulted was caused by "fluxionary hyperaemia of the bronchial mucous membrane."  What he is referring to here is "swelling of the bronchial mucus membrane," wrote Berkart.  This is what we now refer to as inflammation.

Traube also believed asthma was caused by sputum in the air passages of the lungs, according to Jackson.

Ah, if we could only jump into our time machine we could tell Traube he was on the right track.  It would take another 130 years for asthma experts to realize Traube was on the right track, that asthma is a disease of chronic inflammation. 

Likewise, Traube wrote that this inflammation cannot be diagnosed during a person's lifetime, and can only be diagnosed by the symptoms it presents with, such as dyspnea and wheezing.

Then in 1859 Bervenisti, as Berkart continued, brought attention once again to the differentiation of the different causes of lung diseases that he believed were probably unrelated to asthma.  He (Bervenisti) believed that a doctor could not possibly diagnose bronchospasm by listening to lung sounds alone.  That sonorouis and sibilant rhonchi are also present with a pulmonary embolism, which also causes dyspnea.

Once again, if we could jump into our time machine we could tell him he was right, that lung sounds can help with a differential diagnosis.  For example, heart failure would result in coarse crackles throughout the lungs or half way up, pneumonia often results in crackles in one lobe of the lungs, a wheeze indicative of air traveling through narrowed air passages (asthma), and rhonchi indicative of air traveling through sputum (bronchitis).

In a way I'd like Mr. Bervenisti to come talk to the doctors that exist today who still believe all dyspnea is bronchospasm.  I'd like Mr. Bervenisti to set them straight.

Convulsive and nervous theories both win the day:

Jean Antoine Villemin became famous as the person to prove that tuberculosis was contagious after rabbits he injected with tuberculosis from humans contracted the disease.

In 1860 Jean Antoine Villemin tried to disprove the nervous theory with his own scientific experiments, yet once again the nervous theories were so popular Villemin's common sense approach was ignored.

Villemin actually came up with a theory in a circuitous way describing what we now call air trapping. 

Deprived of "nutrition," Berkman wrote in describing Villemin's theory, "the air vesicles (alveoli) became impaired, they were unable to efficiently perform expiration.  At the same time respiratory surface was reduced, and the blood accumulated in the bronchi (inflammation) to such an extent as to convert their mucous membrane into a kind of erectile tissue. 

"This condition gave rise to no symptoms," Berkart continued, "either subjective or objective."  The only time symptoms occurred

Villeman's theory here might be a little off, yet our time traveler would benefit history if he could somehow convince Villemin not to give up trying to convince other experts that they were wrong and he was sort of on the right track.  Your time traveler's attempts might prevent the 130 year delay.

So this is how it went throughout most of the 19th century.  Is asthma caused by the vagus?  Is it spasmotic?  Is it a result of spasms of the diaphragm?  Is it a result of paralysis of the air passages?  Is asthma both spasmotic and emphysema? 

The debate was pretty much ended when Henry Hyde Salter entered the picture.  Salter would become the pre-eminent asthma expert of the second half of the 19th century.  In fact, he was so famous he was even consulted to be the asthma doctor for a boy who would one day become President of the United States (I'll write about that in the coming weeks).

Salter published the original version of "On Asthma:  It's Pathology and Treatment," in 1864 (Salter's book was published prior to Berkarts).  Based on his own experience with asthma, and observations of his own patients, he accurately described the asthma patient during an asthma attack.

He wrote that he saw enough evidence to believe in the spasmotic theory of asthma, yet he also believed that bronchospasms were caused by nervous stimulation.  He also believed asthma was an inflammatory disease and wrote about asthma as a hereditary disorder.

Salter believed some exciting factor (like dust or sterss) was recognized by the abdulla oblongotta, and a signal was sent via the pneumogastric nerve to the bronchiole fibres that wrap around the lungs signalling them to constrict.  In this way asthma was a nervous condition. 

Salter offered the following examples as proof asthma was started in the brain:
  • Many patients feel fine as soon as they enter the doctor's office
  • Mental emotion can bring on a paroxysm of asthma
  • Mental emotion can resolve a paroxysm of asthma
  • Remedies that relax the nervous system resolve asthma, such as tobacco, antispasmodics, and sedatives, nervous depressants. Examples include tobacco, alcohol, morphine, and especially chloroform.
Berkart noted that in 1843 George Hirsh said he (Hirsh) didn't understand how asthma could affect so many boys if it were a nervous disorder. Salter better described this in his book, stating that asthma is a disease that causes the boy to yearn for his mother. It's this yearning that results in an asthma attack.

Thus, it's for this reason Salter justifies using remedies to calm the mind such as smoking cigarettes, alcoholic drinks, formaldehyde, and sedatives. (to see more Salter remedies click here).  Salter didn't deny the convulsive theory of asthma, yet his main focus was on the nervous theory because he believed the mind caused the convulsions or spasms in the lungs.

Pepper and Star explained that by the time the third edition of their book "A System of Practical Medicine" was published in 1885, Williams and Longet's bronchospasm theory of asthma was readily accepted. They wrote that "most modern pathologists have arrived at the conclusion that bronchial asthma is a spasmotic contraction of the middle and finer bronchi dependent on some derangement in the function of the pneumogastric nerve."

Likewise, Whitaker added that "whatever doubt still hung about the contraction of the bronchial tubes themselves would seem to have finally been dissipated by Lazarus (1891), who devised an ingenious apparatus wherewith he could, with the aid of curare and tracheotomy, experiment on animals in life, and whereby he produced the characteristic dyspnea of the disease by irritation of the vagus nerve."

Brenner (page 9) noted that sometime around 1900 Willem Einthoven (the inventor of the EKG) evaluated the bronchospasm theory of asthma and spasming diaphragm theory of asthma and proved the bronchospasm theory.

So based on experiments and personal observation, and with the appraisal of highly rated doctor's like Henry Hyde Salter, the bronchospasm and nervous theory of asthma won the day.  The nervous theory remained popular until it was disproved in the 1950s.  However, it really wasn't until the 1980s that the theory was laid to rest. 

The bronchospasm theory of asthma lives on.

Click here for more asthma history.

References:
  1. Pepper, William,  Louis Star, "A System of Practical Medicine," Volume 3, page 184
  2. Berkart, J.B., "On Asthma: It's pathology and treatment," 1878, London,  Chapter II, "History of Asthma," page 12
  3. Bree, Robert, "A Practical Inquiry into Disordered Respiration, distinguishing the Species of Convulsive Asthma, their Causes, and Indications of Cure, London, 1810.  I could not find the 1790 edition online, yet this one serves our purpose.
  4. Schmiegelow, Ernest, "Asthma, considered specially in relation to nasal disease," 1890, London, page 4 
  5. Jackson, Mark, "Asthma: The biography," 2009, London, pages 86-88 (If you're interested in a good asthma history book, this is it.)
  6.  Bryan, Jenny, "Asthma," 2008, page 8
  7. Floyer, John, ed., "The Cyclopaedia of practical medicine," 1833, volume 1, page 186
  8. Whitaker, James Thomas, "The theory and practice of medicine," 1893
  9. Brenner, Barry E, ed, "Emergency Asthma" 1998, page 7 (chapter one is a history of asthma written by Brenner)
  10. Berkart, J.B.,"On Asthma:  It's Pathology and Treatment, 18xx, volume I, page 23 (Berkart started his book with a good history of asthma up to his time.  I base much of this post on his thorough asthma history.)
  11. Pepper, op cit, page 194
  12. Berkart, op cit, page 27
  13. Daintith, John, "Biographical encyclopedia of scientists."
Other readings:

Tuesday, January 31, 2012

Classic toddler asthma signs easily overlooked

Yes it's true that even your humble RT and lifelong asthmatic can over look the classic signs of asthma.  My 3 YO HM woke at 2:30 in the morning, was agitated, coughing, and was annoying her father.  He even yelled at her, because he thought she was simply caught in that flux between sleep and reality.

He finally set her back in bed and decided she'd eventually fall asleep.  He hopped into his own bed, and his wife said, "Did you give her her pulmicort before bed last night.  Sometimes she has asthma when she doesn't get it."

Bingo!  He could have slapped himself up alongside the head.  He carried the little girl to the living room, set her in the recliner, prepared a breathing treatment with pulmicort and ventolin, and gave it to her by blowby.  Within minutes her breathing was easy and she was sound asleep.  

He set her back in bed and not a peep was heard the rest of the night.  This was a perfect real life example of how even the most expert of asthma experts can overlook the classic signs of asthma.

 It's a also a quintessential example of how important it is that everyone responsible for a child know about the signs of asthma.  When one person misses the signs, perhaps the other will pick up on them.  

I suppose it's also a classic example of the importance of good teamwork.  Regardless, she is doing great today, that little asthma girl.  No longer will we be able to skip a dose of pulmicort.  

Monday, January 30, 2012

2012 Inhaled Corticosteroids on the market

Inhaled corticosteroids continue to be a top line option for treating asthma.  As of January 30, 2012, the following are options available to asthmatics:
  • Aerobid
  • Azmacort
  • Qvar
  • Flovent HFA
  • Azmanex Twisthaler
According to the FDA.gov, any one of the above will work to control asthma.  An interesting thing to note is that the FDA mentioned that every new inhaled corticosteroid to hit the market since beclomethasone in 1960 was just a little stronger and a little safer than the one before it.  If this is true, Azmanex would be the best inhaled corticosteroid.  It's also available in the combination inhaler Dulera (a medicine similar to Advair and Symbicort).

Another neat thing to mention is that the HFA propellant appears to be finer than the CFC propellant, which means the inhaled corticosteroids may get deeper into the lungs to provide better distribution of the medicine.  This has been proven by some studies.  Some hardluck asthmatics have been experimenting taking a few puffs a day of Qvar to go along with their Advair, or Symbicort, or Dulera.

I believe at the present time there will soon be another inhaled steroid on the market, and I think there are already attempts being made to have it released in a combination inhaler with fluticasone (Flovent).  Fluticasone is presently combined with Salmeterol (Sevevent) in Advair.

Thursday, January 26, 2012

1940-2012: The dry powdered inhaler (DPI)

For almost 8,000 years asthmatics inhaled medicine by smoking it.  This changed in the 1930s with the invention of the electric nebulizer and again in the 1950s with the invention of the metered dose inhaler (MDI).  A third option that has been slowly gaining momentum is the Dry Powder Inhaler (DPI). 

A DPI allows you to inhale the powdered version of a medicine, which comes in the form of a capsule or blister that is cracked open inside the inhaler.  There is no propellant, and instead the medicine is breath actuated.  This means the medicine enters your airway as you inhale.  

There are advantages to DPIs:
  1. Since they are breath actuated no propellant is needed
  2. Coordination is generally easy
  3. They are easier to use than MDIs
  4. Dose is easily measured
Of course there are also disadvantages:    
  1. The patient must be able to generate enough flow
  2. Each company markets its own device, which means there may be many to learn
  3. You will have to place the capsule into the device prior to inhaling the medicine
  4. The devicess tend to be expensive to manufacture and expensive to purchase
To learn about the history of DPIs we actually have to travel back to before the first MDIs hit the market in the 1950s.  In fact, according to Mark Sanders in his 2007 article, "Inhalation Therapy: an historic review," the first patent for a DPI was made in 1964 by Newton.  The medicine he used was potassium chlorate, a medicine Sanders notes was ultimately determined to be a lung irritant.

However, while Newton's device wasn't a commercial success, "He observed that the powder needed to be finely pulverized and that it had to be kept dry -- principles that still apply to dry powder inhalers today."  (1)

According to A.R. Clark in his 1995 article, "Medical Aerosol Inhalers: Past, Present, and Future, Aerosol Science and Technology , the first DPI was patented in 1939.  I would imagine he's referring to DPIs that resemble what we use today, as opposed to the Newton's device.  

Clark explained that the 1939 inhaler  was not used as an asthma inhaler, though, but to inhale "aluminum dust  for the chelation of inhaled silica.  It was intended for use by miners who suffered from silicosis induced by inhaling dust."  Yet the product never gained popularity and was never marketed.  (2)

By the 1940s pharmaceutical companies learned that systemic injection of asthma medicines like epinephrine and atropine caused significant side effects.  They were in an all out race to develop a device that allowed asthmatics to inhale medicine and, thus, generate an immediate effect with fewer side effects. 

In 1949 the Aerohaler was introduced as the first marketable DPI, and also the first rescue inhaler.    The medicine was Isoprenaline sulphate.  Yet it never gained popularity and was later overshadowed when the first MDIs hit the market in 1957 in the form of the Medihaler Epi and the Medihaler Iso.

For all practical purposes, it was ultimately realized DPIs don't work well with rescue medicine because when the medicine is needed many asthmatics have trouble generating enough flow to suck up the medicine.  While Ventolin is available overseas as a DPI, none are currently approved by the FDA for sale in the U.S.

When the CFC propellant (see lexicon) used in MDIs was determined to harm the environment in the 1990s, DPIs were determined to be a solid delivery device for asthma controller medications, and this is the main reason they have become a common site in asthmatic homes.

Aerolator with glass vial containing 3 small epi/ penicillin vials
So, without further adieu, here are your DPIs:

1.  Aerohaler:  Released by Abbot laboratories  in 1949 as the first marketed DPI.  The medicine was Norisodrine, isoprenaline sulphate.  It was the first rescue inhaler.  Clark described the Aerohaler this way:  "The device consisted of 'sifter' cartridges containing the powdered dose out of the cartridge and a mouthpiece through which the aerosol was inhaled.  There was very little control over the delivered dose, other than patient symptoms titration, and there was no dispersion mechanism inside the device to aid aerosol generation."  (3)  Each glass vile contained three smaller vials (sifter cartridges) that were set on the inhaler device.  The patient then inhaled the powder through the nose.  The disadvantages of this inhaler were later outshadowed by the release of the MDI in 1957.  The Aerohaler was also used in the late 1940s and 50s as a means to deliver penicillin.  A modern version of the Aerohaler was remarketed and available in some countires, yet it has little in common with the original.  

Intal Spinhaler and Intal Gelcap
 2.  Spinhaler:  Fisons introduced this device in 1971 as the mechanism to deliver disodium cromoglycate (sodium cromolyn or simply cromolyn).  It was approved by the FDA in .  The product was marketed as the Intal Spinhaler to be used with the Intal Spincaps, and remedied many of the problems of the Aerohaler.  It was the first commercially successful DPI.  The caps were made of a hard gelatin and guaranteed the same dose with each inhaletion (a metered dose).  They had to be removed from the foil package and placed in the spinhaler by the patient.  The patient then cocks the outer shell of the inhaler and needles inside the device pierce the capsule.  The patient then places his mouth on the mouthpiece and inhales.  The flow generated causes a fan inside the device to rotate, and as this occurs the powder is inhaled.  The Intal Spinhaler was very popular as an asthma controller medicine during the 1980s and 90.  It was ultimately phased out because the powder caused some patients to cough and this caused some asthma attacks.  It was replaced by the Intal inhaler in the late 1990s.  I wrote more about the Spinhaler here.

Ventolin Rotahaler and Rotacaps
3.  Rotahaler:  In the early 1960s Allen and hanbury introduced the Ventolin Rotacap to go along with the Ventolin Rotahaler.  The product was marketed throughout the 1980s and 1990s but was ultimately discontinued because some asthmatics who needed the rescue medicine had trouble generating enough flow to suck in the medicine.  Another problem was that each individual unit dose Rotacap had to be handled by the patient and carefully inserted into the device.  The Ventolin Rotahaler was a failed experiment, and since it was discontinued only asthma controller medicines have been available as DPIs.  The Rotahaler was later refined so it contained a month supply of capsules and re-marketed as the Becotide Rotohaler and the Spiriva Handihaler in 2009.

4.  Turbuhaler:  Astra Zeneca introduced this product as one of the first multi dose DPIs in the early 1990s. The Pulmicort Turbuhaler was approved by the FDA in 1997, and the Symbicort Turbohaler in 2000, according to FDA.gov.  Various other products have been marketed in other countries such as the Bricanyl Turbuhaler (terbutaline) and Formoterol Oxis Turbuhaler.  The Pulmicort DPI has since been discontinued.

Diskhaler
5.  Diskhaler:  GlaxoSmithKline intruduced the disk in the early 1990s and asked for FDA approval in 1992. The original discus contained 4-8 blisters per cartridge, which made it so the patient didn't have to worry about handling each dose.  The device has since been refined so each discus contains 60 capsules, or two capsules for each day, or one month supply.  The recommended dose is one puff twice daily.  Each disc is equivalent to two puffs of the MDI version of the medicine.  A blister of capsules are stored in a roll, or disc inside the device.  All the patient has to do to prepare a dose is to open the device and pull down a lever.  This moves a new capsule into the delivery chamber and decreases the counter by one so the patient knows how many doses are left. The Serevent Discus was FDA approved in 1997 and the Advair Discus in 2000 according to fda.gov.  The Flovent Discus was approved in 2000 but was never marketed. The Serevent Discus may also be referred to as Seritide, Viani, ForAir, and Foxair in some countries.  Advair is a combination of Serevent and Flovent.  The Advair Discus is currently the most popular asthma controller medicine on the market.  The discus is referred to as the autohaler or diskus in some countries.  Other products available but not approved by the FDA are the Becodisk which contains beclomethasone, and the Ventolin Autohaler

6.  Inhalator:  The device is marketed by Novaris.  I've found various articles that mention studies comparing salmeterol (Serevent) inhaler with the formoterol inhalator (Barotec) from as far back as 1985, although I'm not certain it was actually approved for use in any country at this time.  The inhaler was improved upon by 2001 and renamed the Centihaler.  It was this product that was finally approved by the FDA in 2001 as the Foradil Centihaler.  In 2006 the FDA approved the Foradil Aerolizer which will be under patent until 2019.  (3)  The recommended dose is two puffs of the inhaler twice daily or one puff on the DPI.  As a note here, the FDA seems to have the strictest policy for drug approval.  As a rule of thumb, if the FDA approves a medicine chances are it's been run through the gambit and is proven relatively safe, or at least the benefits far outweigh the disadvantages.  I believe this product was slow to be approved by the FDA due to it being linked to asthma related deaths.  However, many believe it wasn't the medicine so much as poor education that resulted in the deaths, yet it was never proven either way.  A similar problem plagues salmeterol.  The problems was addressed in 2003 with a black box warning on the packaging. 

7.  Cyclohaler:   This is another DPI introduced to the market in the early 1990s.  The medicine is stored in hard gelcaps that are inserted into the cyclohaler with each use.  The mouthpiece is long to optimize drug distribution even if the patient isn't able to generate enough flow. Several puffs were often necessary to get an optimal dose.  The initial product was marketed as the Aerolizer Cyclohaler, and the products available were albuterol and ipatropium bromide.  Since the product wasn't marketed in the U.S. the medicine was referred by it's non-U.S. name, such as the Salbutamol Cyclohaler and Salbutamol Cyclocaps.  The product has since been refined and marketed with other medicines such as  salbutamol (Sultanol), beclomethasone (Becotide), Formoterol (Foradil) and  budesonide (Miflonide).  The latest version is marketed as the cyclohaler 400.

8.  Other:  By 2008 there would be over 20 different DPIs on the market (4), and by 2012 that number would rise to 35.  While many are available for use in Europe, only a select few have been approved by the FDA.  DPIs currently on the market (as of 2012) are (you can view pictures of the various devices here):
  • Acu-Breathe (Respirics)
  • Aerolizer (Novartis)
  • AIR (Civitas/Alkermes)
  • Airmax (Teva)
  • Aspirair (Vectura)
  • Axahaler (S.M.B.)
  • Breezhaler (Novartis)
  • Clickhaler (Vectura)
  • Conix Dry (3M)
  • Cricket (Mannkind)
  • Cyclohaler (Teva)
  • Diskhaler (GlaxoSmithKline)
  • Diskus (GlaxoSmithKline)
  • Dreamboat (Mannkind)
  • Easyhaler (Orion)
  • EZ Aer (Aerovance)
  • Flexhaler (AstraZeneca) -- Pulmicort
  • Genuair (Almirall)
  • Gemini (GSK)
  • Handihaler (Boehringer Ingelheim)
  • MicroDose (MicroDose Therapeutx)
  • Next DPI (Chiesi)
  • Novolizer (Meda)
  • Oximax (Mantecorp)
  • Podhaler (Novartis)
  • Pulmojet (sanofi-aventis)
  • Pulvinal (Chiesi)
  • Skyehaler (SKyepharma)
  • Solis (Sandoz/Novartis)
  • Taifun (Akela)
  • Taper Dry (3M)
  • Trivair (Trimel Bipharma)
  • Twincaps/Flowcaps (Hovione)
  • Twisthaler (Schering /Merck)
  • Turbuhaler (AstraZeneca) (5)
  • Dura Spiros (3M) -- battery powered (introduced in 1990s)
Click here for more asthma history.

References:
  1. Sanders, Mark, "Inhalation therapy:  an historic review," Primary Care Respiratory Journal, 2007, 16 (2), pages 71-81
  2. Clark, A.R., "Medical Aerosol Inhalers: Past, Present, and Future, Aerosol Science and Technology, 1995, 22:4, 374-91
  3. Foradil Aerolizer Briefing Document, Available to the public without redaction, pulmonary drug advisory committee on the safety of long acting beta agonist bronchodilators, fda.gov, http://www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4148B1_02_01-Novartis-Foradil.pdf, page 9
  4. Patterson, Roy, "Patterson's Allergic Diseases," 7th ed., page 610
  5. "Dry Powder Inhalation: Technology, Devices, Markets and Opportunities," prnewswire.com, Jan. 19, 2012, New York, http://www.prnewswire.com/news-releases/dry-powder-inhalation-technology-devices-markets-and-opportunities-137656553.html 

1968-2010: Mast Cell Stabilizers for asthma

Intal Spinhaler used by asthmatics in the 1970s, 80s and 90s
In the early 1980s my doctor introduced me to the Intal Spinhaler that crushed a capsule with a medicine called disodium cromoglycate or chromolyn.  It was a white powder that was proven to improve lung function by decreasing inflammation. 

It was also proven to improve exercise related asthma. 
Each month you'll pick up a small white and yellow box from your pharmacist that contained a bunch of small capsules called Spincaps wrapped in tinfoil.  You unwrapped one and set it aside. 

Now you grab the inhaler and hold it so the mouthpiece is facing down.  You unscrew the cap and place  it onto a cup on the propeller, screw the body back on the mouthpiece, and slide the outer sleeve (the blue part in the picture) down as far as it will go and then back up again.  This pierces the capsule and makes the spinhaler ready for use. (1)

You exhale as much air as you can, place your mouth over the mouthpiece, and inhale.  As you inhale the powder will enter your airway, with a good portion going to your air passages.  You can feel the powder as it enters, and taste it.  This is how you know you did it right. 

This was the first dry powder inhaler that hit the market.  It was a great medicine, and when used with an inhaled corticosteroid it worked great to prevent asthma.

When I was a kid I had what my doctors referred to as high risk asthma. I was allergic to pretty much everything outdoors, and had exercise induced asthma (EIA).  Unless I was in an allergy proof bubble my asthma was usually acting up.  By the time I entered the 9th grade in September of 1984 I pretty much stopped going to gym class per my doctor's instructions.

By January of 1985 I had made so many trips to the ER I was admitted to NJH/NAC in Denver.  Once they managed to get my asthma under control they did some pulmonary function testing (PFT) on me to see what medicine might help me with my EIA. 

In one test I took no medicine and ran on the treadmill.  My lung function dropped significantly.  A week later I did another PFT, this time taking two puffs of Alupent before I ran on the treadmill.  My lung function once again dropped significantly, indicating Alupent had no effect. 

A week later I used my Intal Spinhaler before exercise, and while my lung function declined it wasn't as steep of a decline, indicating that disodium cromoglycate prevented EIA. (You can see my PFT tests here).

Intal Inhaler
I was using this inhaler four times a day (which was a pain in the butt anyway), so there was no need for me to use it prior to every time I exercised.  Yet the medicine was proven to reduce inflammation in your air passages so your asthma triggers don't irritate you as much, and don't constrict your air passages as much.

In a way, it worked the same way inhaled steroids worked, yet apparently not as well.  Prior to being at NJH/NAC my doctors had me using my Intal every day all the time, and only using my inhaled steroids as needed.  Yet by the time I left NJH/NAC in July of 1985 I was using both medicines four times every day, along with a ton of other medicines as you can see here.  Yes, this was a lot of medicine.

Yet the Intal Spinhaler was a good medicine for asthmatics since it was introduced to the market in 1968.  The medicine disodium cromoglycate was isolated by Roger Altounyan who had bad asthma himself and decided to test a variety of substances that were already proven to benefit asthma. He was working at Bengers Research Laboratories.  (2)

Cromolyn Nebulizer Solution
Khella was used by local natives living in Eastern Mediterranean countries for quite a few years to treat asthma with some success.  They made various "concoctions" from the seeds of the plant Amni Vasnaga, from which the substance Khellin was extracted in 1879.  (3)

Various studies in the 1940s and 50s showed the medicine relaxed smooth muscles throughout the body, including the muscles surrounding air passages in the lungs.  Yet the bronchodilating effect was less than epinephrine.  The various studies showed the medicine accumulated in your system if used regularly, and was proven effective for both asthma and other lung diseases. (4)

In 1953 The American Journal of Physical Medicine published the results of a study that showed inhaling aerosols of  7mg of Khellin improved lung function.  Perhaps it was studies like this that inspired Altounyan to study this extract.  (5)

Amps of Cromolyn solution
By experiments in the lab Altounyan produced a safer version of khellin called disodium chromoglycate.  While his goal was to improve his own asthma, what he ended up with was a new product.  It was marketed by Fisons and sold as the Intal Spincaps and Intal Spinhaler.  It became yet another option for many asthmatics worldwide suffering from asthma and allergies. 

Along with being the first dry powder inhaler, it was also the first mast cell stabilizer.  It prevented inflammation by preventing mast cells from releasing the mediators of inflammation (like histamine) which ultimately cause the inflammatory response. 

A problem with the spinhaler was that it couldn't be used during an asthma attack, and the dry powder entered your airway at such a force it was known to cause a fit of coughing and, thus, cause some asthma attacks.  I never experienced this problem however.  It was a nice option for me until modern inhaled steroids made it unnecessary.

Tilade inhaler
Nedicromil Sodium was approved by the FDA in 1992 as an alternative to Intal, and was marketed as the Tilate inhaler. (6) It was equally effective in treating inflammation and reducing allergy and asthma symptoms.  I never used Tilade, and I have little clinical experience educating it to patients either.

By 1995 Chromolyn was available as a solution to be nebulized, and this was ultimately a good option for pediatricians to prescribe for kids with asthma.  I have no recollection of ever giving this via aerosol to an adult, and rarely gave it to kids either for that matter.  I believe we no longer carry it in our stock. 

The Intal Spinhaler was ultimately phased out in the U.S. and Europe in favor of an inhaler, and the inhaler was ultimately phased out on December 31, 2010.  I imagine by information I've read on the Internet it's still a viable and cheap option for some asthmatics in 3rd world nations.  Yet here in the U.S. it's an antique. 

Tilate was phased out on June 14, 2010.  Altounyan's product was a great option for many asthmatics for many years, and for that we owe him thanks.  Perhaps some form of this product will make a comeback someday and replace the need for inhaled corticosteroids. 

References: 
  1. "Intal Spincaps Powder for Inhalation, Sodium cromoglycate, Consumer Medicine Information, " package insert for the Intal Spinhaler and Intal Spincaps, 2005
  2. Jackson, Mark, "Asthma: A biography," 2009, New York, page 187
  3.  Kennedy, M.C.S, J.P.P. Stock, "The Bronchodilator Action of Khellin," Thorax, 1952, 7, 43, pages 43-65
  4. Kennedy, ibid, page 43
  5. Braun, K, E. Eilender, "Khellin Aerosol in Bronchial Asthma," American Journal of Physical Medicine, Dec., 1953, Vol. 32, Issue 6,
  6. "Tilade approved by FDA; Fisons Announces Co-Promotion Agreement with Rhone-Poulenc Rorer," Press Release, TheFreeLibrary.com, http://www.thefreelibrary.com/TILADE+APPROVED+BY+FDA%3B+FISONS+ANNOUNCES+CO-PROMOTION+AGREEMENT+WITH...-a013101159

Monday, January 23, 2012

1781-1826: Laennec: The inventor of the stethoscope

Rene Laennec (1781-1826)
Before the 19th century the only way for a physician to hear heart and lung sounds was to place his ear upon his patent's chest.  This was a method first described by Hippocrates, although it wasn't standard practice.  Of course some patent's were gross and filthy in those days, considering the shower was not common place nor easy for some people.

Likewise, for a gentleman doing this to a lady the experience might be a bit uncomfortable for both the patient and the doctor.  Obesity also posed a problem because fat tissue muffles sound.  When he was 38-years-old on a hot and humid day in 1816 Laenec was posed with all of these problems.

According to Kendall F. Haven in his book "One hundred greatest inventions of all time," Laennec was a "well established doctor and diagnostician of chest and abdominal disorders when he was asked by a fellow physician to assess an obese young woman with breathing difficulties." (1)

Not that it matters, but for the record the patient's name was Marie-Melanie Basset, and she was only 40.

Laennec listens to man with tuberculosis*
Laenec's normal technique was to have the woman partially disrobe so he could place his ear against a hanker chief over her chest.  He'd listen to lung sounds over five spots:  the underside of each arm, each side of upper back, and upper breast bone.  Yet he heard nothing, so he tried percussion.

Percussion is another handy technique to help a doctor diagnose lung disorders.  This was a tecnhique not common worldwide, although in Paris it was.  In fact, percussion was a technique made famous by Laennec's teacher, Jean Nicolas Corvisant.  The doctor would tap on the chest and the sound created would be indicative of different conditions.  Doctors still use the technique to this day. 

For example, asthma causes air to be trapped in the lungs and causes a hollow sound.  Sound travels better through fluid -- like pneumonia -- and amplifies sound.  Once again, however, fat tissue drowns out sound.  While Leannec suspected the lady had heart failure, he was unable to diagnose her by heart and lung sounds.

Thinking off the cuff, however, he "grabbed 24 sheets of paper, rolled them tightly into a bundle, and secured them in shape with paste glue," wrote Haven.  "He applied one end of this paste roll against the young woman's chest, and the other to his ear."

Leanecc was "delighted" to learn he could hear the woman's heart and lung sounds better this way than with the unaided ear against her chest.  He was so excited at how simple a device could make this job so much easier that he set out to do a series of experiments to find metals and tubes that would aid his ear in hearing heart and lung sounds. 

After some tinkering he came up with the perfect device, and you can read more about it and check out some pictures by clicking here at www.hhmi.org.  His device was 12 inches long and about 1.5 cm in diameter with a 3/8 inch bore hold throughout its length, according Antiquemed.com. (2)

He actually wanted to name the device le cylindre claiming it was frivolous to name such a device.  Since he didn't like names given to his device by his colleagues, he later called it a stethoscope.  Dictionary.com defines stethe as Greek for chest and scope is Latin for aim.

Laennec's Stethoscope (1820)**
His model was pretty much a wooden tube that you put in one ear.  In the ensuing years the model was adjusted by others, and eventually a stethoscope with two ear pieces (binaural) was invented.  In 1850 George Camman fine tuned the stethoscope so it was similar to the models we use today.

Later Laennec recollected how a  little kid's game where little kids would listen to sounds through long, hollow sticks. While one end of the stick was held up to the ear, the other was scratched with a pin. The sound would be amplified. He wrote:
"The other method just mentioned [direct auscultation] being rendered inadmissible by the age and sex of the patient, I happened to recollect a simple and well-known fact in acoustics, . . . the great distinctness with which we hear the scratch of a pin at one end of a piece of wood on applying our ear to the other. Immediately, on this suggestion, I rolled a quire of paper into a kind of cylinder and applied one end of it to the region of the heart and the other to my ear, and was not a little surprised and pleased to find that I could thereby perceive the action of the heart in a manner much more clear and distinct than I had ever been able to do by the immediate application of my ear.
He was also skilled with the flute, and this may have helped him come up with his idea as well. By taking a hollowed out tube he was able to create his first sthethescope.

He discovered that his invention was better for hearing sounds inside the human body than the ear alone.  He found it very useful, and would incorporate his new tool as a means of assessing all of his patients.  He likewise used it in his efforts to study many diseases, such as tuberculosis.

Painting of Laennec using his stethoscope***
Yet when he told his peers of his new invention he was ridiculed, wrote Suzanne Barchers, in her book "I've Discovered Sound," (Brainworks, 2009).  "What a ridiculous idea," his colleagues would say.  "We doctors are called upon for our brilliant medical minds.  To say we should carry some frivolous tool around with us is absolutely ridiculous and below us." (3)

One doctor wrote, ""He that hath ears to hear, let him use his ears and not a stethoscope."

Once again the paradigm slows down progress.  So many times during the annals of time people reject change, and this resistance to change was never more paramount than in the medical profession.  For thousands of years physicians rejected any scientific idea that opposed Galen's superstitions, and now they reject a tool that would allow them to do their jobs better.

In fact, Laennec was ridiculed so much that he would end up retiring early and moved to the country side.  Yet Laennec would end up with the last laugh, as by the time he passed away  in August of 1836 the stethescope became a standard tool to assess and diagnose. 

Brainworks explains that Leanec's invention was used to help diagnose many patients with tuberculosis. And when he was 46 "he got very sick.  His own invention confirmed that he had tuberculosis."

To view more pictures of the Laennec stethescope click here.

References:
  1. Haven, Kendall F, "One hundred greatest inventions of all time," 2006, page 96-98
  2. "Now I hear:  The history of the stethoscope,"  http://antiquemed.com/, 1998-2011
  3.  Barchers,Suzanne, "I've Discovered Sound," Brainworks, 2009, page 9
Pictures: